| NCT Number | NCT06627933 |
| Lead Sponsor | I.M. Sechenov First Moscow State Medical University |
| Conditions | Thromboembolism, Anticoagulant-induced Bleeding |
| Enrollment | 1,733 participants |
| Start Date | 2023-01-15 |
| Primary Completion | 2025-01-15 (estimated) |
| Study Completion | 2027-09-10 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-14 |